News › Clinical Practice, Industry News, Patient Care

SculpSure Cleared for Non-Invasive Lipolysis of Back, Inner and Outer Thighs

July 19, 2017

SculpSure has gained expanded clearance from the FDA for the additional treatment of the back as well as inner and outer thighs. Developed by Cynosure, the esthetic division of Hologic, the light-based fat reduction device has previously been cleared for the treatment of the abdomen and flanks.
SculpSure uses a selective wavelength (240W total output) laser to target and permanently eliminate fat cells in problem areas through customized treatment plans, which last approximately 25 minutes. The laser raises the temperature of body fat and disrupts and destroys fat cells, which are then naturally eliminated by the body over time.
Read more at Skin Inc. Magazine >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement
    • Boulevard Launches ePrescribe for Direct In-Platform Med Spa Patient Prescribing
    • Galderma Launches Alastin Regenerating Skin Nectar with TriHex+
    • FDA Moves to Reevaluate Several Peptides